Share this Page:
In 2009, Cesar Fuentes was first diagnosed with kidney cancer (renal cell carcinoma, RCC). He had the tumour removed with surgery, but in 2022, his cancer returned and he was referred to Dr Thomas Hutson at the Baylor University Medical Center in Dallas, Texas. Here, new treatment options were used to treat Cesar’s cancer.
During an Around the Practice® programme, Dr Hutson spoke with Cesar about his diagnosis, his treatment, and any side effects he experienced during treatment. Additionally, Cesar provided some advice for patients and clinicians for how to best approach this disease.
An article in Physician’s Weekly summarises the management of side effects to the pembrolizumab plus lenvatinib combination and how to manage them: Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell Carcinoma.